NIH Not Recommending Convalescent Plasma
There is no solid evidence for or against recommending convalescent plasma to treat patients hospitalized with COVID-19, a government panel says, less than 10 days after the FDA authorized emergency use of the treatment. https://t.co/3meLhw4UEY— NBC News (@NBCNews) September 2, 2020
Health Editor’s Note: In what seemed likely to be a promising treatment for COVID-19 now, after reviewing all the available research, the opinion from the NIH is that there is no solid evidence for or against using convalescent plasma for treatment.
Greater than 72,000 COVID-19 patients have been treated with convalescent plasma but now this treatment is not to be considered a ‘standard of care’ until more randomized, placebo-controlled clinical trials are completed.
Some physicians will continue to use the treatment for the more critical cases since there is nothing else that is more effective.
VT was onboard with this treatment as it made total medical/scientific sense to place antibodies produced by those who have already contracted COVID-19 would cut the strength of COVID-19 infection since the body would be able to have some antibodies, although not those made by their own bodies, to fight the virus…..Carol